Precisionphage
Helsinki, FI · 1 known investors
Find your way into Precisionphage
37 people in our graph share verified history with the Precisionphage team — schools, employers, funds. One of them is your warm intro.
Jason Whitfieldunlockedknows Matti Jalasvuori · together at Australian National University (overlapped)
×9knows the team · via Australian National University
×2knows the team · via University of Jyväskylä
PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.
Founders & leadership
SK
Saija KiljuneninCo-founder
MJ
Matti JalasvuoriinChief Executive Officer (CEO)Matti Jalasvuori is CEO of PrecisionPhage, a Finnish biotechnology company developing bacteriophage-based therapies and computational tools to address antibiotic-resistant bacterial infections.
VH
Ville HoikkalainChief Information Technology Officer (CITO)
LC
Liisa ChistyinFounder
OP
Olli PitkäneninChief Development Officer
Investors · 1
Frequently asked questions
- What does Precisionphage do?
- PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.
- Who founded Precisionphage?
- Precisionphage was founded by Saija Kiljunen.
- Who are Precisionphage's investors?
- Precisionphage's investors include Nordic Science Investments.
- Where is Precisionphage headquartered?
- Precisionphage is headquartered in Helsinki, FI.